The discovery could help explain why some cancer patients respond well to certain treatments, while others are not so lucky.

Manmeet Ahluwalia, MD, MBA, FASCO, discusses the prevalence of brain metastases in patients with primary renal cell carcinoma.

Aiosyn, a pioneering innovator in AI-powered pathology software for cancer and kidney disease, has announced that its ...

MUSC Hollings Cancer Center researcher Aguirre de Cubas, Ph.D., is a recipient of the Department of Defense Academy of Kidney ...

An FDA-approved medication called glucarpidase could serve as an antidote to kidney toxicity in patients receiving the chemotherapy drug methotrexate (MTX), according to a new study. Using data from ...

By Sneha S K and Sriparna Roy (Reuters) - The U.S. Food and Drug Administration said on Friday that it has approved an ...

Fighting cancer can seem like a deadly game of chance. While some patients may respond well to certain treatments, others might not be as fortunate. Doctors and scientists have long struggled to ...

Now scientists have found a possible source of this variability in clear cell renal cell carcinoma (ccRCC) -- the most common kidney cancer diagnosed in adults. Fighting cancer can seem like a ...

An FDA-approved medication called glucarpidase could serve as an antidote to kidney toxicity in patients receiving the chemotherapy drug methotrexate (MTX), according to a new study by investigators ...

I mean I would pay anything. I have to go to the hospital Wednesday,” Ginger Cone said after a weekend blizzard blocked thousands in at home.

James Whale's wife confirmed the TV and radio star was rushed to intensive care last week after being admitted to the ...